HER2 expression and clinicopathological correlates across immunohistochemical phenotypes of urothelial carcinoma: a retrospective single-center study
Human epidermal growth factor receptor 2 (HER2) is a treatment target in urothelial carcinoma (UC), but the features of tumors with HER2 overexpression are not well defined. This study evaluated the clinicopathological factors related to HER2 expression and compared its frequency and tumor characteristics among imm...